NDC 69880-120 – Mycapssa

Octreotide 20 mg/1 · Capsule, Delayed Release · Oral

Human Prescription Drug

Product NDC69880-120

Product details

Brand name
Mycapssa
Generic name
Octreotide
Labeler
Amryt Pharmaceuticals Designated Activity Company
Dosage form
Capsule, Delayed Release
Route
Oral
Marketing category
NDA · NDA208232
Marketed since
July 6, 2020
Listing expires
December 31, 2026
Pharmacologic class
Somatostatin Analog

Active ingredients

Uses, dosage, side effects and warnings for Mycapssa →

Package NDC codes (1)

Package NDCDescriptionSince
69880-120-284 BLISTER PACK in 1 DOSE PACK (69880-120-28) / 7 CAPSULE, DELAYED RELEASE in 1 BLISTER PACKJul 6, 2020

Other Mycapssa products